Anesthetic Management During Cardiopulmonary Bypass: A Systematic Review

被引:58
|
作者
Barry, Aaron E. [1 ]
Chaney, Mark A. [1 ]
London, Martin J. [2 ]
机构
[1] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA
[2] Univ Calif San Francisco, Dept Anesthesiol Serv, San Francisco, CA 94143 USA
来源
ANESTHESIA AND ANALGESIA | 2015年 / 120卷 / 04期
关键词
PLASMA-PROTEIN BINDING; ELECTROENCEPHALOGRAPHIC BISPECTRAL INDEX; HYPOTHERMIC CIRCULATORY ARREST; HEPATIC BLOOD-FLOW; CARDIAC-SURGERY; INTRAOPERATIVE AWARENESS; VOLATILE ANESTHETICS; HIGH-RISK; INFLAMMATORY RESPONSE; ISOFLURANE REQUIREMENTS;
D O I
10.1213/ANE.0000000000000612
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Cardiopulmonary bypass (CPB) required for cardiac surgery presents unique challenges to the cardiac anesthesiologist responsible for providing the 3 most basic facets of any anesthetic: amnesia, analgesia, and muscle relaxation. Unique pathophysiologic changes during CPB result in pharmacokinetic alterations that impact the serum and tissue concentrations of IV and volatile anesthetics. Similarly, CPB causes pharmacodynamic alteration-a that impact anesthetic efficacy. The clinical significance of these alterations represents a "moving target" as practice evolves and the technology of CPB Circuitry advances. In addition, perfusionists choose, modify, and maintain the CPB circuitry and membrane oxygenator. Thus, their significance may not be fully appreciated by the anesthesiologist. These issues have a profound impact on the anesthetic state of the patient. The delivery and maintenance of anesthesia during CPB present unique challenges. The perfusionist may be directly responsible for the delivery of anesthetic during CPB, a situation unique to the cardiac suite. In addition, monitors of anesthetic depth-assessment of clinical signs, hemodynamic indicators, the bispectral index monitor, end-tidal anesthetic concentration, or twitch monitoring-are often absent, unreliable, or directly impacted by the unique pathophysiology associated with CPB. The magnitude of these challenges is reflected in the higher incidence of intraoperative awareness during cardiac surgery. Further complicating matters are the lack of specific clinical guidelines and varying international policies regarding medical device specifications that add further layers of complexity and introduce practice variability both within institutions and among nations. We performed a systematic survey of the literature to identify where anesthetic practice during CPB is evidence based (or not), identify gaps in the literature to guide future investigations, and explore the implications of evolving surgical practice, perfusion techniques, and national policies that impact amnesia, analgesia, and muscle relaxation during CPB.
引用
收藏
页码:749 / 769
页数:21
相关论文
共 50 条
  • [1] Anesthetic management of a patient with myasthenia gravis during hypothermic cardiopulmonary bypass
    Ishimura, H
    Sata, T
    Matsumoto, T
    Takizuka, A
    Shigematsu, A
    [J]. JOURNAL OF CLINICAL ANESTHESIA, 1998, 10 (03) : 228 - 231
  • [2] Anesthetic Management for Cardiopulmonary Bypass: Update for 2014
    Bechtel, Allison
    Huffmyer, Julie
    [J]. SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 18 (02) : 101 - 116
  • [3] Anesthetic management of renal cavoatrial tumor thrombus during partial cardiopulmonary bypass
    Bektas, Serife Gokbulut
    Cavus, Mine Altinkaya
    Turan, Sema
    [J]. TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 26 (04): : 658 - 663
  • [4] ANESTHETIC MANAGEMENT FOR CORONARY SURGERY WITHOUT CARDIOPULMONARY BYPASS
    DUCART, A
    COLLARD, E
    BUCHE, M
    DELIRE, V
    JAMART, J
    BERTIN, M
    BROKA, S
    MAYNE, A
    RANDOUR, P
    JOUCKEN, K
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1995, 74 : 40 - 40
  • [5] The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass
    Mets, B
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2000, 44 (03) : 261 - 273
  • [6] PHARMACOKINETICS OF ANALGESICS, SEDATIVES AND ANESTHETIC AGENTS DURING CARDIOPULMONARY BYPASS
    GEDNEY, JA
    GHOSH, S
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1995, 75 (03) : 344 - 351
  • [7] Management of coagulation during cardiopulmonary bypass
    O'Carroll-Kuehn, Britta U.
    Meeran, Hanif
    [J]. BJA EDUCATION, 2007, 7 (06) : 195 - 198
  • [8] MANAGEMENT OF LUNGS DURING CARDIOPULMONARY BYPASS
    PENNOCK, JL
    PIERCE, WS
    WALDHAUSEN, JA
    [J]. SURGERY GYNECOLOGY & OBSTETRICS, 1977, 145 (06): : 917 - 927
  • [9] Heparin management during cardiopulmonary bypass
    Linden, MD
    Erber, WN
    Schneider, M
    [J]. JOURNAL OF CARDIOVASCULAR SURGERY, 2001, 42 (03): : 431 - 433
  • [10] Temperature Management During Cardiopulmonary Bypass
    Kurusz, Mark
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2010, 24 (02) : 385 - 386